words 33 226 34 Text words 35 3392 36 Abstract 37 Streptococcus pneumoniae is the leading cause of respiratory infection. 38 Although oral hygiene has been considered a risk factor for developing 39 pneumonia, the relationship between oral bacteria and pneumococcal 40 infection is unknown. In this study, we examined the synergic effects of 41 Prevotella intermedia, a major periodontopathic bacterium, on pneumococcal 42 pneumonia. The synergic effects of the supernatant of P. intermedia (Pi Sup) 43 on pneumococcal pneumonia were investigated in mice, and the stimulation 44 of pneumococcal adhesion to human alveolar (A549) cells by Pi Sup was 45 assessed. The effects of Pi Sup on platelet-activating factor receptor (PAFR) 46 transcript levels in vitro and in vivo were analyzed by quantitative real-time
PCR, and the differences between the effects of pneumococcal infection 48 induced by various periodontopathic bacterial species were verified in mice. 49 Mice inoculated with S. pneumoniae plus Pi Sup exhibited a significantly 50 lower survival rate, higher bacterial loads in the lungs, spleen, and blood, and 51 higher inflammatory cytokine levels in the bronchoalveolar lavage fluid 52 (macrophage inflammatory protein-2 and tumor necrosis factor-alpha) than 53 those without Pi Sup. In A549 cells, Pi Sup increased pneumococcal adhesion 54 and PAFR transcript levels. Pi Sup also increased lung PAFR transcript levels 55 in mice. Similar effects were not observed in the supernatants of 56 Porphyromonas gingivalis or Fusobacterium nucleatum. Thus, P. intermedia 57 has the potential to induce severe bacteremic pneumococcal pneumonia with 58 enhanced pneumococcal adhesion to lower airway cells.
Introduction 73 Streptococcus pneumoniae is the leading cause of community-acquired 74 respiratory infections worldwide (1). There are several known risk factors for 75 pneumococcal disease, but limited descriptive data concerning the 76 relationship between oral hygiene and pneumococcal infection. 77 Poor oral hygiene has been suggested to be a risk factor for respiratory disease 78 (2), and several studies indicate that oral care reduces the incidence and 79 mortality of pneumonia in hospitals or nursing homes (3) (4) (5) . Regarding the 80 relationship between S. pneumoniae and oral hygiene, Okuda et al. reported 81 that oral cleansing significantly reduced the detection rates of S. pneumoniae 82 in patients that have undergone oral and maxillofacial surgeries (6). 83 Several oral anaerobes, mostly related to periodontitis, are known to interact 84 in a synergistic or antagonistic manner (7, 8) . To understand the interactions 85 between microorganisms, the enhancement of reciprocal bacterial growth, 86 adhesion/invasion into host cells, and effects on host immunity response have 87 been examined (7) (8) (9) (10) (11) (17). 103 In this study, we examined the effects of P. intermedia on pneumococcal 104 pneumonia in a murine model. The aims of this study were to determine 105 whether P. intermedia exhibits synergic effects on pneumococcal pneumonia 106 and to examine its mechanism of interactions. Pharmaceutical Industrial Co., Tokyo, Japan). To prepare a bacterial 117 suspension, P. intermedia was incubated with modified GAM broth in an 118 anaerobic chamber until it reached its late logarithmic growth phase (24 h). 119 Bacteria were then harvested by centrifugation (3000 rpm, 10 min) and 120 resuspended in normal saline. 121 The supernatants of P. intermedia and the other anaerobes were obtained as 122 previously reported (18, 19) . Briefly, the anaerobes were incubated using 123 modified GAM broth for 48 h in an anaerobic chamber. The supernatants were 124 then collected by centrifugation at 10,000 rpm at 4 °C for 50 min to remove 125 the bacteria and filter-sterilized through a 0.22-µm pore membrane filter 126 (Millipore, Bedford. MA, USA). 127 We conducted all experiments using the PINU499 strain, with the exception 128 of the experiments performed to verify the differences between the effects of 129 periodontopathic bacterial species and strains on pneumococcal infection. We inoculating mice. The final bacterial load of Sp was approximately 2 × 10 6 -2 153 × 10 7 CFU/mL (1 × 10 5 -1 × 10 6 CFU/mouse), and the final bacterial load of P. 154 intermedia was approximately 2 × 10 8 -2 × 10 9 CFU/mL (1 × 10 7 -1 × 10 8 155 CFU/mouse). 156 In experiments that examined the effects of culture supernatants of P. at 37 °C with 5% CO2 in fully humidified air. Cells were exposed to Pi Sup for 196 pneumococcal adhesion studies. For controls, cells were incubated with 197 modified GAM broth, and the pH was adjusted to that of Pi Sup. 198 199 Pneumococcal adhesion to airway cells exposed to Pi Sup in vitro. The 200 adhesion of pneumococci to airway cells in vitro was performed as previously 201 described (21). Briefly, A549 cells were seeded in 24-well plates. Pi Sup was 202 added to cell monolayers, incubated at 37 °C for 4 h, and subsequently 203 removed by washing twice with RPMI medium. Pneumococci was then added 204 and incubated for 2 h. Cell monolayers were washed five times, and cells were 205 removed from the tissue culture plate with trypsin-EDTA and lysed with ice-206 cold sterile distilled water for 10 min. The lysates were then plated to 207 determine the CFU/mL. 208 The functional relevance of platelet-activating factor receptor (PAFR) was 209 also assessed by co-incubating cells with the competitive PAFR antagonist with Pi Sup showed severe bronchopneumonia with massive hemorrhaging 278 (Fig. 2d) . Pi Sup-inoculated mice also exhibited mild hemorrhaging (Fig. 2b) , 279 whereas the lungs of Sp-infected mice without Pi Sup only exhibited mild 280 pneumonia 24 h after inoculation (Fig. 2c ). Broth-inoculated (control) mice 281 did not exhibit any inflammatory changes in the lungs. 282 In order to examine peak inflammatory changes in the lungs of Sp-infected 283 mice with Pi Sup, we performed BAL 36 h after inoculation. The total cell and 284 neutrophil counts (Table 2) were significantly higher in Sp-infected mice with 285 Pi Sup and Pi Sup-inoculated mice than those of Sp-infected mice without Pi 286 Sup. To further examine the differences, inflammatory cytokine levels in 287 BALF were analyzed. TNF-α and MIP-2 concentrations were significantly 288 higher in Sp-infected mice with Pi Sup than those of the other group (Fig. 3) . 289 TNF-α levels also increased slightly in Pi Sup-inoculated groups and were 290 still significantly higher than those of Sp-infected mice without Pi Sup. To Fig. 4C ). 316 In mice, Pi Sup increased lung PAFR transcript levels 6-24 h after inoculation 317 ( Fig. 5A) . To examine the differences between the PAFR transcript levels of 318 Sp-infected mice with/without Pi Sup, we collected the lungs of mice 24 h after 319 inoculation. The highest increase in PAFR transcript levels was observed in 320 the lungs of Sp-infected mice with Pi Sup (p < 0.005 vs Sp without Pi Sup; p 321 < 0.05 vs Pi Sup). The Pi Sup-inoculated group exhibited higher PAFR 322 transcript levels than Sp-infected mice without Pi Sup (p < 0.005). The present study is the first to demonstrate that the products of P. (27). 366 For the reason that P. intermedia itself does not exhibit significant 367 inflammatory or synergic effects on pneumococcal pneumonia in mice, we 368 consider the instability of P. intermedia in lungs. Because of the aerobic 369 environment in the lungs, P. intermedia may not be stable in the lungs, 370 preventing proliferation and the secretion of virulent products. 371 The main goal of our study was to determine the extent by which PAFR 372 expression affects the susceptibility of S. pneumoniae in mice administered 373 Pi Sup, and the data obtained were inconclusive. We treated Sp-infected mice 374 with Pi Sup with CV3988 (PAFR antagonist) but could not determine any 375 significant improvement in survival or attenuation of pneumococcal bacterial 376 load in the lungs or blood (data not shown). However, Pi Sup-induced PAFR 377 up-regulation in our murine model was consistent up to at least 24 h after 378 inoculation. As were able to administer CV3988 only once at the initiation of 379 inoculation, we could not thoroughly determine that treatment failure by 380 CV3988 was due to insufficient drug administration. To investigate the role 381 of PAFR expression induced by Pi Sup in Sp-infected mice, additional 382 experiments that focus on specific P. intermedia products and use PAFR 383 knock-out mice will be necessary,. 384 In this study, we also examined the effects of other periodontopathic bacteria 385 on our murine model. P. gingivalis is a major pathogen of chronic periodontitis 386 (28), and F. nucleatum is a pathogen frequently detected in the lesions of 387 gingivitis, chronic periodontitis, and lower respiratory tract specimens (29, 388 30). 389 One possible mechanism that could increase the presence of periodontopathic 
